Clinical Trials Directory

Trials / Completed

CompletedNCT01860885

Critical Respiratory Events in Children Requiring Naloxone: Naloxone Use as Opioid Safety Measure

Study of Hospital-wide Critical Respiratory Events Requiring Naloxone in a Pediatric Institution

Status
Completed
Phase
Study type
Observational
Enrollment
95 (actual)
Sponsor
Children's Hospital Medical Center, Cincinnati · Academic / Other
Sex
All
Age
1 Day
Healthy volunteers
Not accepted

Summary

Opioids are the mainstay of analgesia in hospitalized children but opioid therapy is associated with life-threatening respiratory depression requiring antagonism with naloxone. Hence, it is hypothesized that naloxone requirement can be used as a quality measure of opioid safety. A retrospective medical chart review of 95 patients, who received naloxone for life threatening events, from June 2006-2012, is planned, to identify significant factors associated with risk for opioid induced respiratory depression and formulation of preventive strategies.

Conditions

Timeline

Start date
2012-08-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2013-05-23
Last updated
2013-05-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01860885. Inclusion in this directory is not an endorsement.